Heparin study for pregnancy with low protein S
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests if low molecular weight heparin improves pregnancy outcomes in women with low protein S activity. If you have low protein S and meet certain criteria, you may join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your protein S activity level is below normal when not pregnant, or your free protein S antigen is below 30% in the second trimester or below 24% in the third trimester.
- You are pregnant and will deliver between August 1, 2024 and October 15, 2027.
- You have a family member with similar symptoms or a personal history of blood clots before age 50, repeated clots, clots in unusual places, or a new clot during or after this pregnancy.
- You do not have other blood clotting disorders, certain immune or blood conditions, or high risk of bleeding.
- You do not have severe high blood pressure, severe liver or kidney problems, or an abnormal uterine cavity.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study looks at a treatment plan for people with systemic lupus (SLE) during pregnancy and tracks health outcomes for mother and baby. It may help doctors learn how to manage SLE safely in pregnancy and what results to expect.
This study looks at the best way to manage blood thinners (like injections of LMWH) during pregnancy for people who need them because of a past or current blood clot risk. It may help by improving how safely and effectively anticoagulation is handled to reduce clot complications.
This study looks at how people’s blood and clotting behave during pregnancy when taking a specific blood thinner called low molecular weight heparin (LMWH) three times a day. It may help doctors fine-tune how safely and effectively LMWH is used during pregnancy.
This trial tests whether a blood-thinning medication (enoxaparin) can help prevent complications like preterm birth or preeclampsia from happening again. It is for people who had a past pregnancy problem tied to placenta blood flow issues.
This trial tests whether adding a daily blood-thinning injection (heparin) to low-dose aspirin helps prevent preeclampsia better than aspirin alone for pregnant women at high risk.
This study is looking at pregnancy outcomes in people who are pregnant and either have antiphospholipid antibody syndrome (APS) or do not have APS but do have prior full-term pregnancies. It may help doctors understand risks and how to manage pregnancies in these groups.
Hear when a new Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.